Interventional Cardiology: Atherectomy and Thromboembolectomy

Interventional Cardiology: Atherectomy and Thromboembolectomy

  • April 2018 •
  • 100 pages •
  • Report ID: 5779861 •
  • Format: PDF
OVERVIEW
The global market for atherectomy and thromboembolectomy products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2016-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually.  This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global atherectomy and thromboembolectomy products market, which includes atherectomy, embolectomy, and thrombectomy products. Primary research querying interventional cardiologists regarding device preferences and utilization was leveraged in the formulation of this report’s forecasts and analyses. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 7.8% during 2016-22, increasing from approximately $1,734.4m in 2016 to an estimated $2,724.5m in 2022. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).